Factor Premiums in Developed vs. Emerging Markets

Factor premiums—the historical outperformance of cheap, small, or high-momentum stocks—are not uniform across global markets. Factor premiums in developed vs. emerging markets vary significantly in size, consistency, and ease of implementation. Developed markets offer well-established factors with lower trading costs but smaller premiums; emerging markets show larger documented premiums but face liquidity, currency, and concentration challenges that erode implementation gains.

The Raw Premium Differential

Academic research on factor returns, starting with Fama and French in the 1990s, has documented consistent premiums for value (cheap stocks outperform), size (small-cap outperforms), and momentum (recent winners continue to outperform) in U.S. markets. Over nearly a century of data, these premiums are real, persistent, and large enough to be economically meaningful.

When researchers extend these studies to emerging markets—particularly China, India, Brazil, and other frontier economies—they find larger raw premiums. An emerging-market value portfolio, buying the cheapest quintile of stocks, has historically outperformed by 5–7% per year. A small-cap factor in emerging markets has delivered 4–7% annual outperformance. These numbers are substantially higher than developed-market equivalents (2–4% for value, 2–3% for size in the U.S. and Europe).

The intuition is straightforward: emerging markets are less efficient. Information is scarcer, retail investors are less sophisticated, and capital is slower to flow toward the cheapest assets or strongest momentum signals. As a result, mispricings persist longer and larger. A value investor buying the cheapest 20% of stocks in Shanghai or Mumbai can find extremes of undervaluation that rarely occur in New York.

The Implementation Reality: Costs Dominate Gains

The gap between raw premium and realized return, however, is dramatically wider in emerging markets.

Developed markets costs:

• Bid-ask spreads: 0.02–0.04% per round-trip trade
• Commissions and fees: Effectively zero to 0.05% (at institutional scale)
• Annual turnover drag for a factor portfolio: ~0.15–0.25% per year
• Currency hedging: Negligible (most accounts are unhedged in USD)

Emerging market costs:

• Bid-ask spreads: 0.20–0.50% per round-trip trade (wider in small-cap and value)
• Trading halts and settlement delays: Occasional liquidity black holes
• Commissions and fees: 0.10–0.30% per trade (higher than developed markets)
• Annual turnover drag: 0.50–1.50% per year (depending on rebalancing frequency)
• Currency hedging (if desired): 0.30–0.50% per year in developed markets’ forwards; higher in emerging markets
• Withholding taxes on dividends: Often 10–15%, sometimes reclaimable but with delay
• Data quality and calculation issues: Pricing errors, corporate actions delays, index reconstitution slippage

When you stack these costs, a 6% raw value premium in emerging markets shrinks to 3–4% net after frictions. The advantage over developed markets, where net premiums run 2–3%, narrows to 1–2% per year before accounting for concentration and currency risk.

Liquidity, Concentration, and Capacity

A developed-market value factor can scale to billions of dollars. The universe of cheap U.S. and European stocks is vast, and daily trading volumes are enormous. An emerging-market value factor, by contrast, faces concentration and capacity constraints.

The typical emerging-market stock universe is dominated by a small number of mega-cap names (a handful of Chinese tech stocks, Indian pharmaceuticals, Brazilian commodities plays). As you move into smaller, cheaper stocks, liquidity dries up. A portfolio manager trying to build a large emerging-market value position will quickly deplete the supply of cheap, liquid stocks and be forced to hold a concentrated, less-liquid portfolio.

This concentration introduces new risks:

Liquidity risk: When the portfolio needs to rebalance or exit, wide bid-ask spreads and low trading volumes mean the portfolio will lose money on the sale.

Single-stock risk: A concentrated emerging-market portfolio is vulnerable to idiosyncratic shocks (a Chinese stock delisting due to regulatory action, a fraud discovery in an Indian microcap) that would be diluted in a broader portfolio.

Momentum reversal in illiquid names: Small emerging-market stocks that show momentum often do so precisely because they are illiquid and have few analysts covering them. When momentum reverses, the reversal is violent.

For large asset managers (BlackRock, Vanguard, Fidelity), capacity constraints are real. An asset manager with $100 billion to deploy in emerging-market factors faces a hard ceiling: after buying every sufficiently liquid cheap stock, there is nowhere else to go. Forced concentration erodes returns.

Factor Consistency and Regime Dependence

Developed-market factors are stable across time. The value factor has worked in bull markets, bear markets, recessions, and booms. Over 80+ years of U.S. market history, value has had bad decades (the 2010s, when growth stocks dominated), but it has never disappeared for long.

Emerging-market factors are less stable. Value premiums can vanish for extended periods. In the 2000s, emerging-market value soared alongside commodity super-cycle and dollar weakness. From 2015 onward, emerging-market value lagged as Chinese growth decelerated and commodity supercycles ended. Momentum factors in emerging markets have been particularly volatile, sometimes working exceptionally well (late 2020–2021), sometimes reversing sharply.

This regime dependence is not pure statistical noise. It reflects real structural shifts: changes in capital controls, regulatory treatment of foreign investors, currency strength, and the emergence of new mega-cap winners (like tech stocks in China). An investor buying emerging-market factors based on historical premiums must accept that future premiums may differ materially from past ones.

Currency Exposure and Hedging Costs

A U.S. investor buying emerging-market stocks faces explicit currency exposure. If the Indian rupee weakens 10% against the dollar, the investor loses 10% in dollar terms even if the stock itself appreciates. Over long periods, currency headwinds can erase factor premiums.

A typical emerging-market value portfolio held unhedged captures both the factor premium (3–5% net) and currency fluctuation (historically −1% to +2% per year for major emerging-market currencies, highly regime-dependent). During periods of “risk-off” sentiment, when global investors flee to dollar safety, emerging-market currencies plummet, turning a factor gain into a net loss.

To hedge currency exposure, investors can use forward contracts or other derivatives. A standard annual hedge costs 0.30–0.50% (the interest-rate differential between emerging-market and developed-market bonds). This shrinks net factor premiums further, narrowing the advantage over developed markets.

Some investors accept unhedged currency exposure as part of their emerging-market allocation, viewing it as a separate diversification bet. But treating currency as implicit adds complexity and tail risk (sharp depreciations during crises).

Regional Variation: Emerging Markets Are Not Monolithic

It is crucial to avoid treating “emerging markets” as a single asset class. Factor dynamics vary sharply across regions.

China: Large, reasonably liquid large-cap index, but state ownership, capital controls, and regulatory uncertainty create risks not present in developed markets. Factor premiums are substantial but often punctuated by policy shocks.

India: Strong fundamentals and economic growth, but smaller overall market cap and lower liquidity in mid-sized companies. Value factor has been attractive, but concentration in a handful of liquid names is severe.

Brazil and Mexico: Commodity-linked economies where factor performance is highly correlated with commodity cycles. Value works when commodities rally; it falters when commodity prices collapse.

Eastern Europe and frontier markets (Vietnam, Philippines): Even more illiquid, smaller universes, higher transaction costs, and limited data quality.

An investor considering emerging-market factors should be specific about which emerging market. A global emerging-market factor portfolio inherits the liquidity and concentration problems of all its parts; a focused bet on a single large, liquid emerging market (e.g., large-cap India) may offer better implementation.

When Emerging-Market Factors Make Sense

Despite the challenges, emerging-market factor exposure can add value in these cases:

1. Long holding periods: Transaction costs matter less over 10+ year horizons. The net premium, even after frictions, can exceed developed-market premiums.

2. Patient capital and low-turnover factors: A buy-and-hold value or quality portfolio turned over annually rebalances less frequently than monthly-rebalanced momentum strategies, cutting costs.

3. Dedicated emerging-market allocation: An investor already committing a slice to emerging markets (for diversification or growth upside) benefits from using factor rules instead of cap-weighted indices, harvesting the premium at the margin.

4. Diversification across factor types: If developed markets are offering weak value premiums (as in the 2010s), supplementing with emerging-market value can improve portfolio diversification.

5. Small allocations: For a $1 million emerging-market allocation, concentration and liquidity are less binding than for a $10 billion allocation. The premium is more likely to survive costs.

Comparative Performance and Volatility

A useful mental model: emerging-market factors deliver higher raw premiums but higher costs, lower liquidity, and more severe drawdowns during risk-off periods. A developed-market factor delivers lower premiums but more consistent, easier-to-capture gains.

Net returns, after costs and currencies, are often similar to developed markets once you account for risk. A emerging-market value portfolio may return 4% net annually with 18% volatility, while a developed-market value portfolio returns 2.5% annually with 12% volatility. The Sharpe ratio (return per unit of risk) may be comparable or favor developed markets.

This argues for portfolio construction: rather than betting all on emerging-market factors, a global factor portfolio that allocates capital proportionally to developed and emerging markets, with slight emerging-market overweights to benefit from higher raw premiums while limiting concentration, may offer the best balance.

See also